IP Library Patent Application 15145618
Patent Application
App. No. 15/145,618

CELL CULTURE PROCESSES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/145,618
Abstract

Culturing heterologous protein-secreting mammalian cells, such as CHO or BHK cells, at 35.1-36.5° C. and/or at pH 7.15-7.20 and/or at a dissolved CO 2 concentration of 10% or lower. Preferred heterologous proteins are Factor VIII, ADAMTS-13, furin or Factor VII.

Claims (26)

1 - 51 . (canceled)

52 . A method comprising:

expressing a heterologous protein in a mammalian cell in continuous cell culture, wherein the continuous cell culture has a dissolved carbon dioxide concentration of from 1% to 10% and is maintained at a cell culture density of from 1.4×10 6 to 2.8×10 6 cells/ml.

53 . The method of claim 52 , wherein the continuous cell culture has a dissolved carbon dioxide concentration of from 4% to 9%.

54 . The method of claim 52 , wherein the continuous cell culture has a dissolved carbon dioxide concentration of from 5.5% to 8.5%.

55 . The method of claim 52 , wherein the continuous cell culture is maintained at a temperature of from 34.2° C. to 36.9° C.

56 . The method of claim 52 , wherein the continuous cell culture is maintained at a temperature of 36±0.9° C.

57 . The method of claim 54 , wherein the continuous cell culture is maintained at a temperature of 36±0.9° C.

58 . The method of claim 52 , wherein the continuous cell culture is maintained at a pH of from 7.10 to 7.25.

59 . The method of claim 52 , wherein the continuous cell culture is maintained at a pH of 7.20±0.05.

60 . The method of claim 54 , wherein the continuous cell culture is maintained at a pH of 7.20±0.05.

61 . The method of claim 56 , wherein the continuous cell culture is maintained at a pH of 7.20±0.05.

62 . The method of claim 57 , wherein the continuous cell culture is maintained at a pH of 7.20±0.05.

63 . The method of claim 52 , wherein the continuous cell culture is buffered with bicarbonate.

64 . The method of claim 52 , wherein the dissolved CO 2 concentration of the continuous cell culture is maintained by sparging the continuous mammalian cell culture with air.

65 . The method of claim 52 , wherein the heterologous protein is a blood protein.

66 . The method of claim 52 , wherein the heterologous protein is Factor VIII.

67 . The method of claim 66 , wherein the Factor VIII is co-expressed with von Willebrand Factor.

68 . The method of claim 52 , wherein the heterologous protein is ADAMTS-13, Furin, or Factor VII.

69 . The method of claim 52 , wherein the continuous cell culture comprises copper at a concentration of at least 5 parts per billion (ppb).

70 . The method of claim 52 , wherein the continuous cell culture comprises copper at a concentration of at least 7 parts per billion (ppb).

71 . The method of claim 52 , wherein the mammalian cell is a rodent cell.

72 . The method of claim 52 , wherein the mammalian cell is a CHO cell.

73 . The method of claim 52 , wherein the mammalian cell is a BHK cell.

74 . The method of claim 52 , wherein the continuous cell culture is operated under chemostatic conditions.

75 . The method of claim 52 , wherein the continuous cell culture is operated under turbostatic conditions.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2021
From: BAXALTA GMBH; BAXALTA INCORPORATED
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 055189/0005 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2018
From: BAXTER INTERNATIONAL INC.
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 045761/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2018
From: BAXTER HEALTHCARE SA
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 045761/0376 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2018
From: BAXTER INTERNATIONAL INC.
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 045401/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2018
From: BAXTER HEALTHCARE SA
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 045400/0211 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2018
From: GIOVAGNOLI, ANDRE; ROY, SYLVAIN; DUCROS, VERONIQUE; CHARLOT, VIRGINIE; STAUFFER, YVES-OLIVIER
To: BAXTER HEALTHCARE SA; BAXTER INTERNATIONAL INC.
Reel/Frame 044987/0443 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2018
From: GIOVAGNOLI, ANDRE; ROY, SYLVAIN; DUCROS, VERONIQUE; CHARLOT, VIRGINIE; STAUFFER, YVES-OLIVER
To: BAXALTA INCORPORATED; BAXALTA GMBH
Reel/Frame 045312/0806 →